A partir de cette page vous pouvez :
| Retourner au premier écran avec les dernières notices... |
Détail de l'auteur
Auteur Lopalco PL
Documents disponibles écrits par cet auteur
Ajouter le résultat dans votre panier Affiner la rechercheAssessing the impact of different BCG vaccination strategies on severe childhood TB in low-intermediate prevalence settings / Manissero D in Vaccine, Vol. 26, N° 18 (04/2008)
Titre : Assessing the impact of different BCG vaccination strategies on severe childhood TB in low-intermediate prevalence settings Type de document : Article scientifique Auteur(s) : Manissero D ; Lopalco PL ; Levy Bruhl D ; Ciofi degli Atti ML ; Giesecke J Appartenance auteur(s) InVS DMI Année de publication : 2008 Article en page(s) : 2253-9 Langues : Anglais (eng)
in Vaccine > Vol. 26, N° 18 (04/2008) . - 2253-9Mots-clés : BCG ; Vaccination ; Tuberculose ; Prévalence ; Politique vaccination ; Modèle ; Europe Résumé : The decrease in overall incidence of TB in industrialised countries, together with the increasing concern for adverse events following BCG immunization, has led to important modifications of BCG policies in the last decades. This article adapts and validates - with surveillance data - a theoretical model estimating the impact of different national BCG vaccination policies on severe childhood TB in low to intermediate TB prevalent countries. The model shows that a universal BCG programme could be beneficial in settings with prevalence levels around 30 sputum smear positive per 100,000. In settings with prevalence levels below 15 per 100,000 the benefit of universal BCG vaccination should be carefully assessed, particularly where prevalence is below 5 per 100,000 and universal vaccination might lead to an excess of adverse events per case prevented. To this purpose the model also provides a tool to assess the theoretical impact of a policy change towards selective 'high-risk groups' vaccination. PMID Pubmed : Pubmed : 18400344 Corpus : Production scientifique InVS Permalink : http://opac.invs.sante.fr/index.php?lvl=notice_display&id=3522 [article]
Titre : Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008-2009 Type de document : Article scientifique Auteur(s) : Mereckiene J ; Cotter S ; D'Ancona F ; Giambi C ; Nicoll A ; Levy Bruhl D ; Lopalco PL ; Weber JT ; Johansen K ; Dematte L ; Salmaso S ; Stefanoff P ; Greco D ; Dorleans F ; Polkowska A ; O'Flanagan D Appartenance auteur(s) InVS DMI Année de publication : 2010 Article en page(s) : pii=19700 Langues : Anglais (eng)
in Eurosurveillance. European communicable disease monthly [Euro Surveill] > Vol. 15, N° 44 (04/11/2010) . - pii=19700Mots-clés : Grippe ; Vaccination ; Politique vaccination ; Union Européenne ; Norvège ; Islande Résumé : In 2009 the second cross-sectional web-based survey was undertaken by the Vaccine European New Integrated Collaboration Effort (VENICE) project across 27 European Union (EU) member states (MS), Norway and Iceland (n=29) to determine changes in official national seasonal influenza vaccination policies since a survey undertaken in 2008 and to compare the estimates of vaccination coverage between countries using data obtained from both surveys. Of 27 responding countries, all recommended vaccination against seasonal influenza to the older adult population. Six countries recommended vaccination of children aged between six months and PMID Pubmed : Pubmed : 21087586 Corpus : Production scientifique InVS Lien(s) externe(s) : http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19700 Permalink : http://opac.invs.sante.fr/index.php?lvl=notice_display&id=476 [article]Documents numériques
10487_PSAdobe Acrobat PDF
Titre : Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe Type de document : Article scientifique Auteur(s) : Mereckiene J ; Cotter S ; Weber JT ; Nicoll A ; D'Ancona F ; Lopalco PL ; Johansen K ; Wasley AM ; Jorgensen P ; Levy Bruhl D ; Giambi C ; Stefanoff P ; Dematte L ; O Flanagan D ; the Vaccine European New Integrated Collaboration Effort (VENICE) project gatekeepers group Appartenance auteur(s) InVS DMI Année de publication : 2012 Article en page(s) : pii=20064 Langues : Anglais (eng)
in Eurosurveillance. European communicable disease monthly [Euro Surveill] > Vol. 17, N° 4 [26/01/2012] . - pii=20064Mots-clés : Nouvelle grippe A (H1N1) ; Vaccination ; Politique vaccination ; Couverture vaccinale ; Union Européenne ; Norvège ; Islande Résumé : In August 2010 the Vaccine European New Integrated Collaboration Effort (VENICE) project conducted a survey to collect information on influenza A(H1N1)pdm09 vaccination policies and vaccination coverage in the European Union (EU), Norway and Iceland. Of 29 responding countries, 26 organised national pandemic influenza vaccination and one country had recommendations for vaccination but did not have a specific programme. Of the 27 countries with vaccine recommendations, all recommended it for healthcare workers and pregnant women. Twelve countries recommended vaccine for all ages. Six and three countries had recommendations for specific age groups in children and in adults, countries for specific adult age groups. Most countries recommended vaccine for those in new risk groups identified early in the pandemic such as morbid obese and people with neurologic diseases. Two thirds of countries started their vaccination campaigns within a four week period after week 40/2009. The reported vaccination coverage varied between countries from 0.4% to 59% for the entire population (22 countries); 3% to 68% for healthcare workers (13 countries); 0% to 58% for pregnant women (12 countries); 0.2% to 74% for children (12 countries). Most countries identified similar target groups for pandemic vaccine, but substantial variability in vaccination coverage was seen. The recommendations were in accordance with policy advice from the EU Health Security Committee and the World Health Organization. (R.A.) PMID Pubmed : Pubmed : 22297139 Corpus : Grippe A(H1N1)/Production scientifique InVS Lien(s) externe(s) : http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20064 Permalink : http://opac.invs.sante.fr/index.php?lvl=notice_display&id=10433 [article]Documents numériques
10433_PSAdobe Acrobat PDF
Titre : Reliable surveillance of tick-borne encephalitis in European countries is necessary to improve the quality of vaccine recommendations Type de document : Article scientifique Auteur(s) : Stefanoff P ; Polkowska A ; Giambi C ; Levy Bruhl D ; O Flanagan D ; Dematte L ; Lopalco PL ; Mereckiene J ; Johansen K ; D'Ancona F Appartenance auteur(s) InVS DMI Année de publication : 2011 Article en page(s) : 1283-8 Langues : Anglais (eng)
in Vaccine > Vol. 29, N° 6 [01/02/2011] . - 1283-8Mots-clés : Lyme ; Vaccination ; Vaccination recommandée ; Union Européenne Résumé : In July-November 2009, 26 European Union (EU) Member States (MSs), Norway and Iceland, participated in a survey seeking information on national tick-borne encephalitis (TBE) vaccination recommendations. Information on TBE surveillance, methods used to ascertain endemic areas, vaccination recommendations, vaccine coverage and methods of monitoring of vaccine coverage were obtained. Sixteen countries (57%) reported presence of TBE endemic areas on their territory. Vaccination against TBE was recommended for the general population in 8 (28%) countries, for occupational risk groups - in 13 (46%) countries, and for tourists going abroad - in 22 (78%) countries. Although vaccination recommendations for country residents, and for tourists always referred to endemic areas, there was no uniform, standardized method used to define endemic areas. For this reason, clear recommendations for tourists need to be developed, and standardized surveillance directed to efficient assessment of TBE risk need to be implemented in European countries. (R.A.) PMID Pubmed : Pubmed : 21145914 Lien externe DOI : DOI : 10.1016/j.vaccine.2010.11.077 Corpus : Production scientifique InVS Permalink : http://opac.invs.sante.fr/index.php?lvl=notice_display&id=378 [article]
Titre : The current state of introduction of HPV vaccination into national immunisation schedules in Europe. Results of the VENICE 2008 survey Type de document : Article scientifique Auteur(s) : Levy Bruhl D ; Bousquet V ; King LA ; O'Flanagan D ; Bacci S ; Lopalco PL ; Salmaso S Appartenance auteur(s) InVS DMI Année de publication : 2009 Article en page(s) : 2709-13 Langues : Anglais (eng)
in European Journal of Cancer [Eur J Cancer] > Vol. 45, N° 15 (10/2009) . - 2709-13Mots-clés : HPV ; Vaccination ; Calendrier vaccinal ; Enquête ; Europe Résumé : Three surveys have been undertaken in European Union (EU) member states since January 2007, within the European Commission funded Vaccine European New Integrated Collaboration Effort (VENICE) project, to monitor the decision status regarding the introduction of human papillomavirus (HPV) vaccination into national immunisation schedules. A web-based questionnaire was developed and completed online by the 28 countries participating in VENICE. According to the last update (31st December 2008), 15 countries have decided to introduce HPV vaccination into their national immunisation schedule, while another six have started the decision-making process with a recommendation favouring introduction. Varying target populations have been selected by the countries which have introduced vaccination. The number of countries which have made a decision or recommendation has increased from 12 to 21 between October 2007 and December 2008. This survey demonstrates the rapidly evolving nature of HPV vaccine introduction in Europe. A further update should be available in the second half of 2009. Corpus : Production scientifique InVS Permalink : http://opac.invs.sante.fr/index.php?lvl=notice_display&id=842 [article]Permalink
